Pharmabridge

What Pharmabridge does

Pharmabridge is a privately held, for-profit contract research and development services firm headquartered in Doylestown, Pennsylvania, United States. According to its stated short description, the company provides contract R&D activities to clients in the pharmaceutical, biotechnology, and agricultural industries, indicating a multi-vertical outsourcing service model rather than a product or platform business. The firm operates at micro-scale, with a disclosed headcount of 1-10 employees, and the only named executive is Chief Executive Officer Tong Xiao.

No substantive information about Pharmabridge's core products, underlying technology, platform architecture, or specific service offerings is available in the source material. The company website (pharmabridgegroup.com) renders only a loader/verification page rather than substantive content, and the aggregated data records show no products, no technology stack, no integrations, no AI capabilities, no certifications, no patents, and no partnerships. Likewise, no customer logos, pricing model, revenue figures, funding history, ownership details, or geographic footprint beyond the Doylestown HQ are disclosed. The revenue model is therefore unverified from public sources, though the service-firm positioning implies fee-for-service or project-based contract revenue typical of small CROs.

Name

Pharmabridge

Website

https://pharmabridgegroup.com

Company type

Private

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Contract Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Contract research services
• Pharmaceutical R&D
• Biotechnology research
• Drug development services
• Agricultural research

Headquarters

HQ city

Doylestown

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

Pharmabridge provides contract research and development activities serving the pharmaceutical, biotechnology, and agricultural industries. Operating from Doylestown, United States, the firm offers outsourced R&D support through a small team of 1-10 employees to clients across these sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Research and Development Services Outsourced research and development activities delivered to pharmaceutical, biotechnology, and agricultural industry clients.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Celerion: Specialized early-stage clinical CRO focused on bioequivalence, pharmacokinetics, and first-in-human studies. Comparable as a contract research services firm targeting pharma and biotech sponsors with specialized scientific capabilities.
• Frontage Laboratories: Contract research organization providing laboratory and R&D services to pharmaceutical, biotechnology, and agrochemical companies. Closely comparable to Pharmabridge given the explicit multi-vertical service scope spanning pharma, biotech, and agricultural industries.
• Medpace Holdings: Mid-sized CRO focused on clinical development services for emerging and mid-tier biopharma sponsors. Comparable as a science-led contract research provider serving smaller and mid-sized pharma and biotech clients, with a similar lean operational ethos.
• Worldwide Clinical Trials: Mid-sized global CRO providing clinical and bioanalytical services to biopharma. Comparable as a mid-tier contract research services competitor serving pharmaceutical and biotechnology clients.

Broad incumbents

• Syneos Health: Biopharma solutions organization providing clinical and commercial contract services. Comparable in addressing the same pharmaceutical and biotechnology outsourcing market, though focused more downstream on clinical and commercialization than discovery R&D.
• ICON plc: Major global CRO providing outsourced drug and device development services. Comparable as a contract research services competitor targeting pharmaceutical and biotechnology sponsors.
• IQVIA: World's largest CRO with end-to-end clinical and R&D services for pharma and biotech. Comparable in serving the same sponsor base, but at vastly greater scale and with a global operating footprint.
• WuXi AppTec: Global contract R&D platform offering discovery, preclinical, and manufacturing services to pharma and biotech. Comparable as an end-to-end contract research services provider, though operating at significantly greater scale.
• Charles River Laboratories: Large global CRO offering discovery, safety assessment, and manufacturing services to pharma and biotech. Comparable as a contract R&D services provider to pharmaceutical and biotechnology clients, though materially larger and broader in scope than Pharmabridge.
• Labcorp Drug Development (formerly Covance): Large CRO within Labcorp offering nonclinical, clinical, and central lab services. Comparable in delivering contract R&D to pharma and biotech, but at a fundamentally different scale.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmabridge